Evidence map›Paper›PMID 36818692›Full record

ArticleFrontiers in toxicology2023

Paraxanthine safety and comparison to caffeine.

Sandra K Szlapinski, Andrew Charrette, Najla Guthrie, Corey J Hilmas

Open access · goldAbstract read
In one paragraph

Article in Frontiers in toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sandra K SzlapinskiKGK Science Inc, Division of Client Services, Department of Regulatory Affairs, London, ON, Canada.
Andrew CharretteKGK Science Inc, Division of Client Services, Department of Regulatory Affairs, London, ON, Canada.
Najla GuthrieKGK Science Inc, Division of Client Services, Department of Regulatory Affairs, London, ON, Canada.
Corey J HilmasKGK Science Inc, Division of Client Services, Department of Regulatory Affairs, London, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

1,7-dimethylxanthinecaffeinemethylxanthineparaxanthinepreclinicalrodentsafety assessmenttoxicology assessment

Identifiers

PMID36818692
PMCPMC9932512
OpenAlexW4319018124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.